BRAPP2

Poster BRAPP 2 ICMLugano 2021
Thomas Gastinne

Brentuximab vedotin as consolidation treatment in patients with stage I/II classical Hodgkin’s lymphoma and a positive FDG-PET after 2 cycles of ABVD : a LYSA phase 2 study

 

ICMLugano Thomas Gastinne Abstract N°199